IRVING, Texas — BioTE(R) Medical announces a forum of medical experts gathering before the Age Management Medicine Group (AMMG) to form consensus on testosterone therapy in women.
The Age Management Medicine Group (AMMG) conference runs April 27-30, 2017 in Orlando, Florida. Learn more: https://www.agemed.org/.
Nine experts, from across the United States, spanning a variety of medical disciplines and specialties, will present data then defend and vet topics related to testosterone therapy in women.
They will form a consensus and present their position at the next AMMG Conference in November in Tucson, Arizona. Their work will be submitted to medical journals for publication with the goal of gaining widespread support for the use of testosterone therapy in women.
Testosterone has shown to be one of the most cardio-protective hormones and the consensus group will make recommendations that could significantly improve healthcare and reduce heart disease in women – the number one cause of death in women and men in the United States.
Most of the research commentary on BHRT focuses on the effects of testosterone therapy in men. Yet, the data is there to support the health advantages in women. Women derive many of the same benefits from testosterone therapy as men regarding muscle mass, strength, and libido. Additionally, BHRT is protective to the brain, breast, bones, and heart. It helps reverse the annoying symptoms of declining hormones like fatigue, low energy, difficulty inability to lose weight, and irritability and it can increase bone density and help prevent age-related illnesses like osteoporosis and Alzheimer’s.
Click on the link below to hear Founder and CEO of BioTE(R) Medical, Gary S. Donovitz, M.D. share the truth about hormone therapy and the critical need for this consensus.
Video (YouTube): https://youtu.be/kLecmEk7Vtg
For information on the AMMG Conference visit https://www.agemed.org/.
BioTE(R) Medical was founded by physicians for physicians and is committed to excellence in educating doctors and clients about the health benefits of bioidentical hormone pellet therapy. BioTE(R) is headquartered in Irving, Texas and has thousands of certified medical practitioners nationwide. See more about BioTE at http://www.BioTEmedical.com/.
*PHOTO for media: Send2Press.com/mediaboom/17-0419s2p-Gary-Donovitz-300dpi.jpg
*Photo Caption: BioTE(R) Medical Founder and CEO, Gary S. Donovitz M.D.
This news story was published by the Neotrope® News Network – all rights reserved.